News & Articles
Tag: Dr. Anna Burke
DBS Surgery Provides New Hope for Patients with Alzheimer’s Disease
Inclusion Criteria for the ADvance II study: At least 65 years old Mild Alzheimer’s disease On a stable dose of cholinesterase inhibitor 60 days prior to consent (donepezil,...
Barrow Seeks Participants for New Alzheimer’s Drug Trial
Barrow Neurological Institute is screening participants for a new clinical trial that will evaluate the drug troriluzole in people with mild to moderate Alzheimer’s disease. The drug may...